• Government Insurers Balk At Paying For CAR-T Cancer Drug

    NPR | Treatment costs for the immunotherapy can run to more than $1 million. Some state Medicaid programs aren't paying for the treatment, and Medicare's complicated payment rates have hospitals worried.

    Jul 17, 2018

  • Another CRISPR Calamity? U.K. Team Reports CRISPR-Induced Gene Rearrangements

    GEN | Scientists at the Wellcome Sanger Institute in the U.K. have reported another potential hurdle for the CRISPR community, publishing findings today that call the precision of CRISPR-Cas9 gene editing into question.

    Jul 16, 2018

  • Leaders In Biobanking Congress: Unlocking The Potential

    Bio-IT World | This year, the 10th annual Leaders in Biobanking Congress will take place in Cleveland, Ohio from October 14-16. Biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners will converge to discuss the various aims for biospecimen collections, from basic research to clinical trials.

    Jul 16, 2018

  • Superbugs Win Another Round As Big Pharma Leaves Antibiotics

    Bloomberg | The fight against life-threatening infections suffered another blow when one of the world's biggest drugmakers waved the white flag. Novartis is the latest drug giant to end antibacterial and antiviral research, joining the like of AstraZeneca, Sanofi, and Allergan.

    Jul 13, 2018

  • I'm Adopted, Should I Have DNA Testing?

    Forbes | Should adoptees, or parents of adoptees, consider direct-to-consumer genetic testing kits to gain more information on health risks, ancestry, or to find biological relatives? A certified genetic counselor reviews the pros and cons you should know before you spit.

    Jul 11, 2018

  • BioIVT Acquires Optivia, Adding Transporter Assay Products And Services To Its ADME-Tox Portfolio

    Bio-IT World Brief | BioIVT today announced that it has acquired Santa Clara, CA-based Optivia and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.

    Jul 9, 2018

  • JUWELS Becomes Germany’s Most Powerful Supercomputer

    TOP500 | The first module of JUWELS, a supercomputer that is expected to be a model for future exascale systems, is now up and running at the Jülich Supercomputing Centre in Germany.

    Jul 5, 2018

  • Why Data Science Is An Art – And How To Support The People Who Do It

    Elsevier Connect | In his recent talk at the Bio-IT World Conference, Elsevier’s Jabe Wilson used examples of data science undertaken at Elsevier to illustrate why data science is an art – and how best to support data scientists based on this insight.

    Jul 3, 2018